98%
921
2 minutes
20
Importance: Neonatal hypoglycemia is common, but its association with later neurodevelopment is uncertain.
Objective: To examine associations between neonatal hypoglycemia and neurocognitive outcomes at corrected age 2 years.
Design, Setting, And Participants: Exploratory cohort analysis of the Hypoglycaemia Prevention With Oral Dextrose (hPOD) randomized clinical trial was conducted. The trial recruited participants from January 9, 2015, to May 5, 2019, with follow-up between January 26, 2017, and July 31, 2021. Infants were recruited from 9 maternity hospitals in New Zealand and assessed at home or in a research clinic. Children born late preterm and at term at risk of neonatal hypoglycemia but without evidence of acute or imminent illness in the first hour after birth were screened and treated to maintain blood glucose concentrations greater than or equal to 47 mg/dL.
Exposures: Hypoglycemia was defined as any blood glucose concentration less than 47 mg/dL, recurrent as 3 or more episodes, and severe as less than 36 mg/dL.
Main Outcomes And Measures: Neurologic examination and tests of development (Bayley III) and executive function. The primary outcome was neurosensory impairment (any of the following: blindness, deafness, cerebral palsy, developmental delay, or executive function total score worse than 1.5 SD below the mean).
Results: A total of 1197 of 1321 (91%) eligible children were assessed at a mean of corrected age 24 months; 616 (52%) were male. Compared with the normoglycemia group, children who experienced hypoglycemia were more likely to have neurosensory impairment (111 [23%] vs 125 [18%]; adjusted risk ratio [aRR], 1.28; 95% CI, 1.01-1.60), particularly if they experienced severe episodes (30 [28%] vs 125 [18%]; aRR, 1.68; 95% CI, 1.20-2.36), but not recurrent episodes (12 [19%] vs 125 [18%]; aRR, 1.06; 95% CI, 0.63-1.80). The risk of cognitive, language, or motor delay was similar between groups, but children who experienced hypoglycemia had lower Bayley-III composite cognitive (adjusted mean difference [aMD], -1.48; 95% CI, -2.79 to -0.18) and motor scores (aMD, -2.05; 95% CI, -3.30 to -0.79).
Conclusions And Relevance: In children born at risk of hypoglycemia but otherwise well, those who experienced neonatal hypoglycemia were more likely to have neurosensory impairment at corrected age 2 years, with higher risks after severe episodes. Further research is required to determine causality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554702 | PMC |
http://dx.doi.org/10.1001/jamanetworkopen.2022.35989 | DOI Listing |
Indian J Endocrinol Metab
July 2025
Department of Endocrinology, Indraprastha Apollo Hospitals, New Delhi, India.
The significance of hypoglycaemia during oral glucose tolerance tests (OGTT) in pregnancy is uncertain. This systematic review and meta-analysis (SRM) evaluated if hypoglycaemia during OGTT predicts feto-maternal outcomes. Electronic databases were searched for studies in pregnancy where an OGTT at 24-28 weeks was done and feto-maternal outcomes were documented.
View Article and Find Full Text PDFDiabetes Technol Ther
September 2025
Disciplina de Obstetricia, Departamento de Obstetricia e Ginecologia da Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
To assess the relationship between time in range (TIR), extrapolated from self-monitoring of blood glucose (SMBG) measures, and adverse perinatal outcomes in pregnant women with type 1 diabetes (T1D). A retrospective cohort study was conducted, including singleton pregnancies that began antenatal care before 20 weeks of gestation and delivered live newborns without malformations between 2010 and 2019. Glycemic data from SMBG were categorized into TIR (63-140 mg/dL or 3.
View Article and Find Full Text PDFEndocrinology
September 2025
Department of Physiology and Biophysics, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo, Sao Paulo, SP, 05508-000, Brazil.
Growth hormone (GH) acts as a master regulator of body growth in addition to playing a crucial role in various physiological processes. GH is produced by somatotropic cells in the anterior pituitary gland, and its levels in the blood display a pulsatile pattern. Secretion of GH is primarily regulated by hypothalamic factors released into the hypophyseal portal system.
View Article and Find Full Text PDFCureus
August 2025
Mother and Child Health Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Congenital hyperinsulinism (CHI) is a rare but significant cause of persistent neonatal hypoglycemia (NH), associated with a high risk of neurological complications if not promptly treated. This condition is characterized by inappropriate insulin secretion, often of genetic origin, independent of blood glucose levels. We report the case of a male macrosomic newborn admitted on the second day of life for respiratory distress, generalized seizures, and severe hypoglycemia (1.
View Article and Find Full Text PDFJ Paediatr Child Health
September 2025
Endocrinology Service, KK Women's and Children's Hospital, Singapore, Singapore.
Introduction: Neonatal glucose regulation undergoes a rapid transition after birth, with glucose levels declining within the first few hours before stabilising. At-risk neonates, including those who are preterm, small-for-gestational-age (SGA), large-for-gestational-age (LGA), or born to mothers with diabetes or obesity, face an increased risk of hypoglycaemia. Early feeding is recommended to support glucose homeostasis, yet the impact of feeding type on glucose trends and hypoglycaemia risk remains unclear.
View Article and Find Full Text PDF